These results provide a strong rationale for our findings that miR-203a-3p inhibits BE cells growth and affects cell cycle progression by suppression of Gli1, which further testifies that miR-203a-3p/Gli1 mediate the anti-tumor effects of omeprazole in BE cells. The gene discussed is GLI1; the disease is Barrett esophagus.